What the CEOs See
Four biotech leaders on the recession, venture capital, and how their industry can help lead Massachusetts into a recovery
The Boston Globe - May 19, 2009

The hot, burning core of any recovery in Massachusetts could well be occupied by the state's life sciences companies; for evidence, take the preponderance of biotech firms on this year's Globe 100.

With so much of the state's economic future riding on the fortunes of these companies, many of which began life as venture-funded start-ups, it seemed fitting to gather for this year's Globe 100 executive roundtable four captains of the industry: chief executives Henri Termeer of Genzyme Corp. in Cambridge, James Foster of Charles River Laboratories in Wilmington, Joshua Boger of Vertex Pharmaceuticals of Cambridge, and Martin Madaus of Millipore Corp. in Billerica.

Click here to read edited excerpts of their conversation with each other, and with Globe reporter Todd Wallack and Globe 100 editor Michael Warshaw.

Click here to watch a video with their comments.